KRAS

There are 142 papers on KRAS in aging research: 2 trials and 37 observational studies in people, 53 in animals, 21 in cells, 21 reviews. The newest story, Oct 2, 2026: “T cell KRAS upregulation is linked to premature coronary disease”.

Gene

142 papers study it36 findings

HGNCNCBI GeneTaxon

7 new papers in 30 daysSee all 142 papers on KRAS

At a glance

One human preprint links KRAS to premature coronary artery disease in effector CD8+ T cells and to cellular senescence in coronary and carotid plaques.

36 findings in 18 papers from 1992 to 2026, 3 of them since August 2026

The findings reach people, from one lab or study. 14 independent labs in 6 countries; 41 trials, 4 with no results posted.

“KRAS mutation was significantly enriched in patients with higher SAT, VAT and BMI ≥25 kg/m2”
AI-derived body composition analysis reveals muscle volume and metformin-associated adipose effects and the obesity paradox in non-small cell lung cancerEBioMedicine2025doi:10.1016/j.ebiom.2025.105995

3 of its findings point the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 14 independent labs in 6 countries
  • 3 findings against
  • 41 trials, 4 with no results posted
  • Funders: National Cancer Institute and others
  • 2 of 31 findings with company ties
  • 41 of 41 trials sponsored by developers of drugs aimed at it
  • Human trial2
  • Humans37
  • Animals52
  • Model organisms1
  • Cells21
  • In silico6

Interventions

2

Dapagliflozin

downin human cells1

1 study
  1. Dapagliflozin decreases KRAS in vitro.

    “significant downregulation of oncogenic and inflammatory markers (KRAS, IL-6, TGF-β, TNF-α)”

    Cellsin vitroDAPA-PVA-SA-NPsHCT-116 colorectal cancer cells

    A repurposing Dapagliflozin via polymeric nanogels for colorectal cancer therapy

    Scientific reports

More on Dapagliflozin

Caloric restriction

downin rats1

1 study
  1. Caloric restriction decreases KRAS in rats during hepatic regeneration.

    “The expression of c-fos and c-Ki-ras mRNAs, activated during hepatic regeneration, was reduced by CCI.”

    Animalsduring hepatic regenerationliver10 weeks

    Influence of calorie restriction on oncogene expression and DNA synthesis during liver regeneration

    Proceedings of the National Academy of Sciences of the United States of America

More on Caloric restriction

Effects

19

Cellular senescence

downin chicken cells1upin human cells1

2 studies
  1. KRAS decreases cellular senescence in chicken cells (overexpression in chicken granulosa cells).

    “KRAS delayed cellular senescence by reducing SA-β-gal activity”

    Cellsoverexpression in chicken granulosa cellsovarian granulosa cells

    Transcriptome analysis reveals KRAS as a crucial regulator of ovarian follicle development in Wuding chickens

    BMC genomics

  2. KRAS induces cellular senescence in human cells (doxycycline-induced mutant KRASV12 expression in hTERT/Cdk4-immortalized HBEC3 cells) (only a small cell subset).

    “Upon mutant KRASV12 expression, only a small HBEC3-RIN2 cell subset underwent senescence, as assessed by a senescence-associated β-galactosidase staining (SA-βG) method.”

    Cellsdoxycycline-induced mutant KRASV12 expression in hTERT/Cdk4-immortalized HBEC3 cells

    Resistance to mutant KRASV12-induced senescence in an hTERT/Cdk4-immortalized normal human bronchial epithelial cell line

    Experimental cell research

More on Cellular senescence

Apoptosis

downin chicken cells1upin mouse cells1

2 studies
  1. KRAS decreases apoptosis in chicken cells (overexpression in chicken granulosa cells).

    “KRAS inhibited GC apoptosis by increasing antiapoptotic genes (BCL2, TGF-β) and decreasing proapoptotic genes (Caspase 3, BAX)”

    Cellsoverexpression in chicken granulosa cellsovarian granulosa cells

    Transcriptome analysis reveals KRAS as a crucial regulator of ovarian follicle development in Wuding chickens

    BMC genomics

  2. KRAS increases apoptosis in mouse cells (etoposide treatment).

    “K-Ras4A deficiency inhibited etoposide-induced apoptosis in ES cells and intestinal epithelial cells.”

    Cellsetoposide treatmentembryonic stem cells, intestinal epithelium

    The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice

    Experimental cell research

More on Apoptosis

Lifespan

downin mice1no changein mice1

2 studies
  1. KRAS shortens lifespan in mice (KrasG12D activation in old (19-24 months) versus young (3-5 months) mice).

    “Activation of KrasG12D in old mice resulted in shorter survival”

    AnimalsKrasG12D activation in old (19-24 months) versus young (3-5 months) mice

    Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene-induced lung tumors in aged mice

    Aging cell

  2. KRAS showed no clear effect on lifespan in mice.

    “K-Ras4A deficiency did not affect life expectancy or spontaneous overall tumor incidence in aging mice.”

    Animals

    The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice

    Experimental cell research

cell-cycle progression

upin chicken cells1

1 study
  1. KRAS increases cell-cycle progression in chicken cells (overexpression in chicken granulosa cells).

    “KRAS facilitated cell cycle progression by reducing the G0/G1 phase population and increasing the S phase”

    Cellsoverexpression in chicken granulosa cellsovarian granulosa cells

    Transcriptome analysis reveals KRAS as a crucial regulator of ovarian follicle development in Wuding chickens

    BMC genomics

Granulosa cell proliferation

upin chicken cells1

1 study
  1. KRAS increases granulosa cell proliferation in chicken cells (overexpression in chicken granulosa cells).

    “KRAS also promoted GC proliferation by increasing cell viability, stimulating DNA synthesis”

    Cellsoverexpression in chicken granulosa cellsovarian granulosa cells

    Transcriptome analysis reveals KRAS as a crucial regulator of ovarian follicle development in Wuding chickens

    BMC genomics

Progesterone and estradiol production

upin chicken cells1

1 study
  1. KRAS increases progesterone and estradiol production in chicken cells (overexpression in chicken granulosa cells).

    “Overexpression of KRAS significantly enhanced the production of progesterone (P4) and estradiol (E2)”

    Cellsoverexpression in chicken granulosa cellsovarian granulosa cells

    Transcriptome analysis reveals KRAS as a crucial regulator of ovarian follicle development in Wuding chickens

    BMC genomics

More on Progesterone and estradiol production

oncogene-induced senescence

upin reviews1

1 study
  1. KRAS induces oncogene-induced senescence (mutant KRAS expression in normal cells in experimental models).

    “mutant KRAS expression in normal cells often induces oncogene-induced senescence rather than unlimited proliferation”

    Reviewmutant KRAS expression in normal cells in experimental models

    Why isn't an oncogenic mutation in KRAS enough to induce and sustain transformation?

    Critical reviews in oncology/hematology

Mitochondrial reactive oxygen species

upin reviews1

1 study
  1. KRAS increases mitochondrial reactive oxygen species (mutant KRAS).

    “Mutant KRAS increases mitochondrial reactive oxygen species (ROS), which trigger acinar-to-ductal metaplasia”

    Reviewmutant KRASpancreas

    Redox signaling in the pancreas in health and disease

    Physiological reviews

More on Mitochondrial reactive oxygen species

cell cycle status

no changein human cells1

1 study
  1. KRAS showed no clear effect on cell cycle status in human cells (doxycycline-induced mutant KRASV12 expression in HBEC3-RIN2 cells).

    “but did not affect cell division, or cell cycle status”

    Cellsdoxycycline-induced mutant KRASV12 expression in HBEC3-RIN2 cells

    Resistance to mutant KRASV12-induced senescence in an hTERT/Cdk4-immortalized normal human bronchial epithelial cell line

    Experimental cell research

P21 protein expression

upin human cells1

1 study
  1. KRAS increases P21 protein expression in human cells.

    “but increased p21 protein expression by prolonging its half-life”

    Cellsdoxycycline-induced mutant KRASV12 expression; increase via prolonged p21 protein half-life

    Resistance to mutant KRASV12-induced senescence in an hTERT/Cdk4-immortalized normal human bronchial epithelial cell line

    Experimental cell research

More on P21 protein expression

All 19

Upstream

1

circRNA-0077930

upin human cells1

1 study
  1. circRNA-0077930 increases KRAS in human cells (transmitted by high-glucose-stimulated HUVEC exosomes).

    “up-regulation of Kras, p21, p53 and p16 expression”

    Cellstransmitted by high-glucose-stimulated HUVEC exosomesvascular smooth muscle cells

    CircRNA-0077930 from hyperglycaemia-stimulated vascular endothelial cell exosomes regulates senescence in vascular smooth muscle cells

    Cell biochemistry and function

Associations

10

Premature coronary artery disease

upin humans1

1 study
  1. KRAS is associated with premature coronary artery disease in humans.

    “Elevated KRAS expression in senescent, cytotoxic CD8 + T cells is associated with PCAD”

    HumansCD8+ T cell

    Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

    Research SquarePreprint

More on Premature coronary artery disease

Cell killing (cytotoxicity)

mixedin silico1

1 study
  1. KRAS is associated with cell killing (cytotoxicity) in silico network perturbation.

    “Network perturbation of KRAS strongly impacted the cell killing pathway.”

    In silicoin silico network perturbation

    T cell KRAS upregulation is linked to premature coronary disease

    bioRxivPreprint

More on Cell killing (cytotoxicity)

High-risk histopathological features

upin humans1

1 study
  1. KRAS is associated with high-risk histopathological features in humans (13% to 51% mutant samples).

    “there was a stepwise increase in the proportion of samples with a mutation in KRAS from 13% to 51% (padj<0.001) and TP53 from 8% to 35% (padj<0.001)”

    Humansin conventional adenomas, as the number of high-risk features (size ≥10mm, villous architecture, high-grade dysplasia) increasedcolorectal adenoma

    Classical driver mutations are not associated with metachronous lesion risk in patients undergoing post-polypectomy surveillance following removal of conventional adenomas in a bowel screening setting

    medRxivPreprint

Older age

upin humans1

1 study
  1. KRAS is associated with older age in humans (patients aged >50 vs ≤50 years) (72.7% vs. 28.1%, p = 0.001).

    “KRAS mutations were significantly more frequent in older patients (p-value = 0.001)”

    Humanspatients aged >50 vs ≤50 yearscolorectal tumorn = 54

    Age-Related Multigene Analysis of Colorectal Cancer Using Next-Generation Sequencing

    Cancers

Higher adiposity

upin humans1

1 study
  1. KRAS is associated with higher adiposity in humans (KRAS mutation status).

    “KRAS mutation was significantly enriched in patients with higher SAT, VAT and BMI ≥25 kg/m2”

    HumansKRAS mutation status

    AI-derived body composition analysis reveals muscle volume and metformin-associated adipose effects and the obesity paradox in non-small cell lung cancer

    EBioMedicine

More on Higher adiposity

microRNA

mixedin reviews1

1 study
  1. KRAS is associated with microRNA.

    “pathways activated by KRAS can modify the levels of specific miRNAs, establishing a feedback loop that balances cell regulation and tumor progression”

    Review

    Interaction between microRNA and KRAS in Glioblastoma

    Current medicinal chemistry

More on microRNA

microRNAs

mixedin reviews1

1 study
  1. microRNAs is associated with KRAS.

    “we identify certain miRNAs that directly impact KRAS through mRNA targeting or by influencing its downstream signaling cascades”

    Review

    Interaction between microRNA and KRAS in Glioblastoma

    Current medicinal chemistry

PIP4K2C

no changein human cells1

1 study
  1. PIP4K2C is associated with KRAS in human cells (isoform-specific interactor identified by comparative proteomics).

    “including HRAS-specific CARM1 and CHK1 and KRAS-specific PIP4K2C and IPO7”

    Cellsisoform-specific interactor identified by comparative proteomics

    A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent RAS Interactions

    Molecular & cellular proteomics : MCP

More on PIP4K2C

Non-small cell lung cancer

upin humans1

1 study
  1. KRAS is associated with non-small cell lung cancer in humans among TP53-mutant tumors; 47% carried an actionable pathogenic variant (28% of TP53-mutant NSCLC patients (KRAS)).

    “Forty-seven percent of NSCLC patients harboring TP53 mutations also had a mutation in at least one actionable pathogenic variant”

    Humansamong TP53-mutant tumors; 47% carried an actionable pathogenic variant

    Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing

    Neoplasia (New York, N.Y.)

More on Non-small cell lung cancer

Colon adenocarcinoma

upin humans1

1 study
  1. KRAS is associated with colon adenocarcinoma in humans among TP53-mutant tumors with at least one pathogenic gene mutation (33% of TP53-mutant colon adenocarcinoma patients with a pathogenic gene mutation).

    “of which 14% were BRAF, 33% were KRAS, and 3% were NRAS”

    Humansamong TP53-mutant tumors with at least one pathogenic gene mutation

    Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing

    Neoplasia (New York, N.Y.)

More on Colon adenocarcinoma

Funding

3 grants since 2024

National Cancer Institute$2.5MEuropean Commission€216K

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 10Feb 2026: 8Mar 2026: 5Apr 2026: 3May 2026: 1Jun 2026: 3Jul 2026: 2Aug 2026: 3Sep 2026: 3Oct 2026: 3Nov 2026: 447 papers in 12 months
bioRxiv

T cell KRAS upregulation is linked to premature coronary disease

Profiling blood and plaque samples from 12 patients and 21 controls linked elevated KRAS in senescent CD8+ T cells to premature coronary artery disease.Profiling blood and plaque samples from 12 patients and 21 controls linked elevated KRAS in senescent CD8+ T cells to premature coronary artery disease.

Preprint: case-control study of 21 peopleKRAS

See all 142 papers on KRAS